First Citizens Financial Corp’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.14K | Hold |
35,100
| – | – | ﹤0.01% | 124 |
|
|
2025
Q1 | $5.09K | Hold |
35,100
| – | – | ﹤0.01% | 121 |
|
|
2024
Q4 | $3.51K | Hold |
35,100
| – | – | ﹤0.01% | 121 |
|
|
2024
Q3 | $4.21K | Hold |
35,100
| – | – | ﹤0.01% | 121 |
|
|
2024
Q2 | $6.67K | Hold |
35,100
| – | – | ﹤0.01% | 114 |
|
|
2024
Q1 | $14K | Hold |
35,100
| – | – | 0.01% | 113 |
|
|
2023
Q4 | $20.7K | Hold |
35,100
| – | – | 0.01% | 111 |
|
|
2023
Q3 | $18.4K | Hold |
35,100
| – | – | 0.01% | 111 |
|
|
2023
Q2 | $6.67K | Buy |
+35,100
| New | +$6.67K | ﹤0.01% | 112 |
|
|
2022
Q4 | $11K | Hold |
35,100
| – | – | 0.01% | 100 |
|
|
2022
Q3 | $15K | Hold |
35,100
| – | – | 0.01% | 92 |
|
|
2022
Q2 | $15K | Hold |
35,100
| – | – | 0.01% | 100 |
|
|
2022
Q1 | $44K | Hold |
35,100
| – | – | 0.03% | 103 |
|
|
2021
Q4 | $46K | Hold |
35,100
| – | – | 0.03% | 105 |
|
|
2021
Q3 | $72K | Hold |
35,100
| – | – | 0.06% | 100 |
|
|
2021
Q2 | $55K | Hold |
35,100
| – | – | 0.04% | 114 |
|
|
2021
Q1 | $78K | Hold |
35,100
| – | – | 0.06% | 106 |
|
|
2020
Q4 | $89K | Hold |
35,100
| – | – | 0.08% | 105 |
|
|
2020
Q3 | $86K | Hold |
35,100
| – | – | 0.09% | 101 |
|
|
2020
Q2 | $125K | Hold |
35,100
| – | – | 0.13% | 95 |
|
|
2020
Q1 | $82K | Buy |
+35,100
| New | +$82K | 0.11% | 79 |
|